-
1
-
-
0004878466
-
Cross-national epidemiology of major depression and bipolar disorder
-
M.M. Weissman R.C. Bland G.J. Canino et al. Cross-national epidemiology of major depression and bipolar disorder J Am Med Assoc 276 1996 293-299
-
(1996)
J. Am. Med. Assoc.
, vol.276
, pp. 293-299
-
-
Weissman, M.M.1
Bland, R.C.2
Canino, G.J.3
-
2
-
-
0001065199
-
On the propyl derivatives and decomposition products of ethylacetoacetate
-
B.S. Burton On the propyl derivatives and decomposition products of ethylacetoacetate Am Chem J 3 1882 385-395
-
(1882)
Am. Chem. J.
, vol.3
, pp. 385-395
-
-
Burton, B.S.1
-
4
-
-
62149101756
-
Communication concerning 1st clinical tests of the anticonvulsive activity of N-dipropylacetic acid (sodium salt)
-
G. Carraz R. Fau R. Château J. Bonnin Communication concerning 1st clinical tests of the anticonvulsive activity of N-dipropylacetic acid (sodium salt) Ann Med Psychol (Paris) 122 1964 577-585
-
(1964)
Ann. Med. Psychol. (Paris)
, vol.122
, pp. 577-585
-
-
Carraz, G.1
Fau, R.2
Château, R.3
Bonnin, J.4
-
5
-
-
3242724333
-
The history of valproate in clinical neuroscience
-
T.R. Henry The history of valproate in clinical neuroscience Psychopharmacol Bull 37 Suppl 2 2003 5-16
-
(2003)
Psychopharmacol. Bull.
, vol.37
, Issue.SUPPL. 2
, pp. 5-16
-
-
Henry, T.R.1
-
6
-
-
0028045747
-
Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy
-
R. Davis D.H. Peters D. McTavish Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy Drugs 47 1994 332-372
-
(1994)
Drugs
, vol.47
, pp. 332-372
-
-
Davis, R.1
Peters, D.H.2
McTavish, D.3
-
9
-
-
3242745360
-
Divalproex in the treatment of migraine
-
F.G. Freitag Divalproex in the treatment of migraine Psychopharmacol Bull 37 Suppl 2 2003 98-115
-
(2003)
Psychopharmacol. Bull.
, vol.37
, Issue.SUPPL. 2
, pp. 98-115
-
-
Freitag, F.G.1
-
10
-
-
3042576479
-
Valproic acid: An old drug newly discovered as inhibitor of histone deacetylases
-
M. Gottlicher Valproic acid: An old drug newly discovered as inhibitor of histone deacetylases Ann Hematol 83 Suppl 1 2004 S91-S92
-
(2004)
Ann. Hematol.
, vol.83
, Issue.SUPPL. 1
-
-
Gottlicher, M.1
-
11
-
-
18244383806
-
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
-
M. Gottlicher S. Minucci P. Zhu et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells Eur Mol Biol Org J 20 2001 6969-6978
-
(2001)
Eur. Mol. Biol. Org. J.
, vol.20
, pp. 6969-6978
-
-
Gottlicher, M.1
Minucci, S.2
Zhu, P.3
-
12
-
-
0842325787
-
Histone deacetylase is a target of valproic acid-mediated cellular differentiation
-
N. Gurvich O.M. Tsygankova J.L. Meinkoth P.S. Klein Histone deacetylase is a target of valproic acid-mediated cellular differentiation Cancer Res 64 2004 1079-1086
-
(2004)
Cancer Res.
, vol.64
, pp. 1079-1086
-
-
Gurvich, N.1
Tsygankova, O.M.2
Meinkoth, J.L.3
Klein, P.S.4
-
13
-
-
0035965343
-
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
-
C.J. Phiel F. Zhang E.Y. Huang M.G. Guenther M.A. Lazar P.S. Klein Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J Biol Chem 276 2001 36734-36741
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 36734-36741
-
-
Phiel, C.J.1
Zhang, F.2
Huang, E.Y.3
Guenther, M.G.4
Lazar, M.A.5
Klein, P.S.6
-
14
-
-
0036721055
-
Anti-tumor mechanisms of valproate: A novel role for an old drug
-
R.A. Blaheta J. Cinatl Jr Anti-tumor mechanisms of valproate: A novel role for an old drug Med Res Rev 22 2002 492-511
-
(2002)
Med. Res. Rev.
, vol.22
, pp. 492-511
-
-
Blaheta, R.A.1
Cinatl Jr., J.2
-
15
-
-
3142692649
-
Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1
-
R. Tang A.M. Faussat P. Majdak et al. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1 Leukemia 2004
-
(2004)
Leukemia
-
-
Tang, R.1
Faussat, A.M.2
Majdak, P.3
-
16
-
-
0038675351
-
Valproic acid increases the stimulatory effect of estrogens on proliferation of human endometrial adenocarcinoma cells
-
G. Graziani L. Tentori I. Portarena M. Vergati P. Navarra Valproic acid increases the stimulatory effect of estrogens on proliferation of human endometrial adenocarcinoma cells Endocrinology 144 2003 2822-2828
-
(2003)
Endocrinology
, vol.144
, pp. 2822-2828
-
-
Graziani, G.1
Tentori, L.2
Portarena, I.3
Vergati, M.4
Navarra, P.5
-
17
-
-
13344288299
-
-
National Library of Medicine Clinical Trials.gov.U.S. National Library of Medicine, National Institute of Health
-
National Library of Medicine 2004 Clinical Trials.gov.U.S. National Library of Medicine, National Institute of Health, http://www.clinicaltrials.gov/ct/gvi/search?term=valproi
-
(2004)
-
-
-
18
-
-
4444309863
-
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid
-
A. Kvendgen C. Strupp M. Aivado et al. Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid Blood 104 2004 1266-1269
-
(2004)
Blood
, vol.104
, pp. 1266-1269
-
-
Kvendgen, A.1
Strupp, C.2
Aivado, M.3
-
19
-
-
0002721046
-
Valproic acid: Absorption, distribution, and excretion
-
Levy RH, Mattson RH, Meldrum BS, editors New York: Raven Press
-
Levy RH, Shen DD. Valproic acid: Absorption, distribution, and excretion. In: Levy RH, Mattson RH, Meldrum BS, editors. Antiepileptic drugs. New York: Raven Press. 1995, p. 605-619.
-
(1995)
Antiepileptic Drugs
, pp. 605-619
-
-
Levy, R.H.1
Shen, D.D.2
-
21
-
-
0036402177
-
Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy
-
W. Loscher Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy CNS Drugs 16 2002 669-694
-
(2002)
CNS Drugs
, vol.16
, pp. 669-694
-
-
Loscher, W.1
-
22
-
-
0018168207
-
Distribution of valproate across the interface between blood and cerebrospinal fluid
-
H.H. Frey W. Loscher Distribution of valproate across the interface between blood and cerebrospinal fluid Neuropharmacology 17 1978 637-642
-
(1978)
Neuropharmacology
, vol.17
, pp. 637-642
-
-
Frey, H.H.1
Loscher, W.2
-
23
-
-
0037742375
-
Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action
-
W. Loscher Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action Prog Neurobiol 58 1999 31-59
-
(1999)
Prog. Neurobiol.
, vol.58
, pp. 31-59
-
-
Loscher, W.1
-
24
-
-
0019379046
-
Protein binding of valproic acid in the presence of elevated free fatty acids in patient and normal human serum
-
C.L. Zimmerman I.H. Patel R.H. Levy D. Edwards S.D. Nelson M. Hutchinson Protein binding of valproic acid in the presence of elevated free fatty acids in patient and normal human serum Epilepsia 22 1981 11-17
-
(1981)
Epilepsia
, vol.22
, pp. 11-17
-
-
Zimmerman, C.L.1
Patel, I.H.2
Levy, R.H.3
Edwards, D.4
Nelson, S.D.5
Hutchinson, M.6
-
25
-
-
0034754829
-
Intravenous valproate in status epilepticus
-
B.M. Hodges J.E. Mazur Intravenous valproate in status epilepticus Ann Pharmacother 35 2001 1465-1470
-
(2001)
Ann. Pharmacother.
, vol.35
, pp. 1465-1470
-
-
Hodges, B.M.1
Mazur, J.E.2
-
26
-
-
0023952434
-
Treatment of status epilepticus by sodium valproate
-
M. Giroud R. Dumas Treatment of status epilepticus by sodium valproate Neurophysiol Clin 18 1988 21-32
-
(1988)
Neurophysiol. Clin.
, vol.18
, pp. 21-32
-
-
Giroud, M.1
Dumas, R.2
-
27
-
-
0019297753
-
Studies on distribution and metabolism of valproate in rat brain, liver, and kidney
-
M.I. Aly A.A. Abdel-Latif Studies on distribution and metabolism of valproate in rat brain, liver, and kidney Neurochem Res 5 1980 1231-1242
-
(1980)
Neurochem. Res.
, vol.5
, pp. 1231-1242
-
-
Aly, M.I.1
Abdel-Latif, A.A.2
-
28
-
-
0020610769
-
Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment
-
W. Loscher H. Nau Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment J Pharmacol Exp Ther 226 1983 845-854
-
(1983)
J. Pharmacol. Exp. Ther.
, vol.226
, pp. 845-854
-
-
Loscher, W.1
Nau, H.2
-
29
-
-
0030111301
-
Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter
-
K.D. Adkison D.D. Shen Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter J Pharmacol Exp Ther 276 1996 1189-1200
-
(1996)
J. Pharmacol. Exp. Ther.
, vol.276
, pp. 1189-1200
-
-
Adkison, K.D.1
Shen, D.D.2
-
31
-
-
0036354778
-
In vivo evidence for brain-to-blood efflux transport of valproic acid across the blood-brain barrier
-
A. Kakee H. Takanaga K. Hosoya Y. Sugiyama T. Terasaki In vivo evidence for brain-to-blood efflux transport of valproic acid across the blood-brain barrier Microvasc Res 63 2002 233-238
-
(2002)
Microvasc. Res.
, vol.63
, pp. 233-238
-
-
Kakee, A.1
Takanaga, H.2
Hosoya, K.3
Sugiyama, Y.4
Terasaki, T.5
-
32
-
-
0034711537
-
Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: A microdialysis study
-
J.L. Scism K.M. Powers A.A. Artru L. Lewis D.D. Shen Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: A microdialysis study Brain Res 884 2000 77-86
-
(2000)
Brain Res.
, vol.884
, pp. 77-86
-
-
Scism, J.L.1
Powers, K.M.2
Artru, A.A.3
Lewis, L.4
Shen, D.D.5
-
33
-
-
0032562111
-
Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells
-
H. Huai-Yun D.T. Secrest K.S. Mark et al. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells Biochem Biophys Res Commun 243 1998 816-820
-
(1998)
Biochem. Biophys. Res. Commun.
, vol.243
, pp. 816-820
-
-
Huai-Yun, H.1
Secrest, D.T.2
Mark, K.S.3
-
34
-
-
0001395089
-
Valproic acid: Chemistry and biotransformation
-
Levy JH, Mattson RH, Meldrum BS, editors 4th ed
-
Baillie TA Sheffels PR. Valproic acid: Chemistry and biotransformation. In: Levy JH, Mattson RH, Meldrum BS, editors. Antiepileptic drugs, 4th ed, p. 589-604.
-
Antiepileptic Drugs
, pp. 589-604
-
-
Baillie, T.A.1
Sheffels, P.R.2
-
35
-
-
0037086594
-
Complete beta-oxidation of valproate: Cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase
-
M.F. Silva J.P. Ruiter H. Overmars et al. Complete beta-oxidation of valproate: Cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase Biochem J 362 2002 755-760
-
(2002)
Biochem. J.
, vol.362
, pp. 755-760
-
-
Silva, M.F.1
Ruiter, J.P.2
Overmars, H.3
-
36
-
-
0025731391
-
Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats
-
R.L. Semmes D.D. Shen Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats Epilepsia 32 1991 232-241
-
(1991)
Epilepsia
, vol.32
, pp. 232-241
-
-
Semmes, R.L.1
Shen, D.D.2
-
37
-
-
0017837845
-
Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse
-
W. Loscher Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse J Pharmacol Exp Ther 204 1978 255-261
-
(1978)
J. Pharmacol. Exp. Ther.
, vol.204
, pp. 255-261
-
-
Loscher, W.1
-
38
-
-
0002118926
-
Valproic acid toxicity
-
Levy RH, Mattson RH, Meldrum BS, editors 4th ed. NewYork: Raven Press
-
Dreifuss FE. Valproic acid toxicity. In: Levy RH, Mattson RH, Meldrum BS, editors Antiepileptic drugs, 4th ed. NewYork: Raven Press. p. 641-648.
-
Antiepileptic Drugs
, pp. 641-648
-
-
Dreifuss, F.E.1
-
40
-
-
0344889130
-
The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: A pharmacoepidemiology study
-
C.A. Zarate Jr M. Tohen R. Narendran et al. The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: A pharmacoepidemiology study J Clin Psychiatr 60 1999 232-236
-
(1999)
J. Clin. Psychiatr.
, vol.60
, pp. 232-236
-
-
Zarate Jr., C.A.1
Tohen, M.2
Narendran, R.3
-
41
-
-
0019965961
-
Maternal valproic acid and congenital neural tube defects
-
[letter]
-
E. Robert P. Guibaud Maternal valproic acid and congenital neural tube defects [letter] Lancet 2 1982 937
-
(1982)
Lancet
, vol.2
, pp. 937
-
-
Robert, E.1
Guibaud, P.2
-
42
-
-
10544238106
-
Valproic acid-induced somite teratogenesis in the chick embryo: Relationship with Pax-1 gene expression
-
G.L. Barnes Jr B.D. Mariani R.S. Tuan Valproic acid-induced somite teratogenesis in the chick embryo: Relationship with Pax-1 gene expression Teratology 54 1996 93-102
-
(1996)
Teratology
, vol.54
, pp. 93-102
-
-
Barnes, G.L.1
Mariani, B.D.2
Tuan, R.S.3
-
43
-
-
0031694133
-
Studies on the teratogen pharmacophore of valproic acid analogues: Evidence of interactions at a hydrophobic centre
-
U. Bojic K. Ehlers U. Ellerbeck et al. Studies on the teratogen pharmacophore of valproic acid analogues: Evidence of interactions at a hydrophobic centre Eur J Pharmacol 354 1998 289-299
-
(1998)
Eur. J. Pharmacol.
, vol.354
, pp. 289-299
-
-
Bojic, U.1
Ehlers, K.2
Ellerbeck, U.3
-
44
-
-
0028313164
-
Valproic acid-induced neural tube defects
-
H. Nau Valproic acid-induced neural tube defects Ciba Found Symp 181 1994 144-152
-
(1994)
Ciba Found. Symp.
, vol.181
, pp. 144-152
-
-
Nau, H.1
-
45
-
-
0026994501
-
Valproic acid induced abnormal development of the central nervous system of three species of amphibians: Implications for neural tube defects and alternative experimental systems
-
A. Oberemm F. Kirschbaum Valproic acid induced abnormal development of the central nervous system of three species of amphibians: Implications for neural tube defects and alternative experimental systems Teratog Carcinog Mutagen 12 1992 251-262
-
(1992)
Teratog. Carcinog. Mutagen.
, vol.12
, pp. 251-262
-
-
Oberemm, A.1
Kirschbaum, F.2
-
46
-
-
2442716465
-
The relationship between polycystic ovary syndrome and antiepileptic drugs: A review of the evidence
-
N. Rasgon The relationship between polycystic ovary syndrome and antiepileptic drugs: A review of the evidence J Clin Psychopharmacol 24 2004 322-334
-
(2004)
J. Clin. Psychopharmacol.
, vol.24
, pp. 322-334
-
-
Rasgon, N.1
-
47
-
-
0036321395
-
Reproductive dysfunction in women with epilepsy: Recommendations for evaluation and management
-
J. Bauer J.I. Isojarvi A.G. Herzog et al. Reproductive dysfunction in women with epilepsy: Recommendations for evaluation and management J Neurol Neurosurg Psychiatr 73 2002 121-125
-
(2002)
J. Neurol. Neurosurg. Psychiatr.
, vol.73
, pp. 121-125
-
-
Bauer, J.1
Isojarvi, J.I.2
Herzog, A.G.3
-
48
-
-
0038575815
-
Polycystic ovary syndrome and epilepsy: A review of the evidence
-
R. Meo L. Bilo Polycystic ovary syndrome and epilepsy: A review of the evidence Drugs 63 2003 1185-1227
-
(2003)
Drugs
, vol.63
, pp. 1185-1227
-
-
Meo, R.1
Bilo, L.2
-
49
-
-
0033754306
-
Valproate-induced alterations in testosterone, estradiol and progesterone secretion from porcine follicular cells isolated from small- and medium-sized ovarian follicles
-
E. Gregoraszczuk A.K. Wojtowicz E. Tauboll E. Ropstad Valproate-induced alterations in testosterone, estradiol and progesterone secretion from porcine follicular cells isolated from small- and medium-sized ovarian follicles Seizure 9 2000 480-485
-
(2000)
Seizure
, vol.9
, pp. 480-485
-
-
Gregoraszczuk, E.1
Wojtowicz, A.K.2
Tauboll, E.3
Ropstad, E.4
-
50
-
-
0042071485
-
Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells
-
E. Tauboll E.L. Gregoraszczuk A. Kolodziej M. Kajta E. Ropstad Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells Epilepsia 44 2003 1014-1021
-
(2003)
Epilepsia
, vol.44
, pp. 1014-1021
-
-
Tauboll, E.1
Gregoraszczuk, E.L.2
Kolodziej, A.3
Kajta, M.4
Ropstad, E.5
-
51
-
-
0842334582
-
Valproate potentiates androgen biosynthesis in human ovarian theca cells
-
V.L. Nelson-DeGrave J.K. Wickenheisser J.E. Cockrell et al. Valproate potentiates androgen biosynthesis in human ovarian theca cells Endocrinology 145 2004 799-808
-
(2004)
Endocrinology
, vol.145
, pp. 799-808
-
-
Nelson-DeGrave, V.L.1
Wickenheisser, J.K.2
Cockrell, J.E.3
-
52
-
-
0842304131
-
Effect of epilepsy and antiepileptic drugs on male reproductive health
-
J.I. Isojarvi E. Lofgren K.S. Juntunen et al. Effect of epilepsy and antiepileptic drugs on male reproductive health Neurology 62 2004 247-253
-
(2004)
Neurology
, vol.62
, pp. 247-253
-
-
Isojarvi, J.I.1
Lofgren, E.2
Juntunen, K.S.3
-
54
-
-
0034084382
-
Effects of valproic acid on fertility and reproductive organs in male rats
-
T. Nishimura M. Sakai H. Yonezawa Effects of valproic acid on fertility and reproductive organs in male rats J Toxicol Sci 25 2000 85-93
-
(2000)
J. Toxicol. Sci.
, vol.25
, pp. 85-93
-
-
Nishimura, T.1
Sakai, M.2
Yonezawa, H.3
-
55
-
-
0037799006
-
Safety of available agents used to treat bipolar disorder: Focus on weight gain
-
C.B. Nemeroff Safety of available agents used to treat bipolar disorder: focus on weight gain J Clin Psychiatr 64 2003 532-539
-
(2003)
J. Clin. Psychiatr.
, vol.64
, pp. 532-539
-
-
Nemeroff, C.B.1
-
56
-
-
0037400763
-
Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients
-
U. Zimmermann T. Kraus H. Himmerich A. Schuld T. Pollmacher Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients J Psychiatr Res 37 2003 193-220
-
(2003)
J. Psychiatr. Res.
, vol.37
, pp. 193-220
-
-
Zimmermann, U.1
Kraus, T.2
Himmerich, H.3
Schuld, A.4
Pollmacher, T.5
-
57
-
-
0035185642
-
Bodyweight gain and anticonvulsants: A comparative review
-
P. Jallon F. Picard Bodyweight gain and anticonvulsants: A comparative review Drug Saf 24 2001 969-978
-
(2001)
Drug Saf.
, vol.24
, pp. 969-978
-
-
Jallon, P.1
Picard, F.2
-
58
-
-
0028318560
-
A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy
-
Adult EPITEG Collaborative Group
-
A. Richens D.L. Davidson N.E. Cartlidge D.J. Easter A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group J Neurol Neurosurg Psychiatr 57 1994 682-687
-
(1994)
J. Neurol. Neurosurg. Psychiatr.
, vol.57
, pp. 682-687
-
-
Richens, A.1
Davidson, D.L.2
Cartlidge, N.E.3
Easter, D.J.4
-
59
-
-
0028891208
-
A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy
-
The Paediatric EPITEG Collaborative Group
-
C.M. Verity G. Hosking D.J. Easter A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group Dev Med Child Neurol 37 1995 97-108
-
(1995)
Dev. Med. Child. Neurol.
, vol.37
, pp. 97-108
-
-
Verity, C.M.1
Hosking, G.2
Easter, D.J.3
-
62
-
-
0030852379
-
Weight gain in epileptic patients during treatment with valproic acid: A retrospective study
-
C.L. Corman N.M. Leung A.H. Guberman Weight gain in epileptic patients during treatment with valproic acid: A retrospective study Can J Neurol Sci 24 1997 240-244
-
(1997)
Can. J. Neurol. Sci.
, vol.24
, pp. 240-244
-
-
Corman, C.L.1
Leung, N.M.2
Guberman, A.H.3
-
63
-
-
0019494319
-
Effects of sodium valproate in 100 children with special reference to weight
-
J. Egger E.M. Brett Effects of sodium valproate in 100 children with special reference to weight Br Med J (Clin Res Ed) 283 1981 577-581
-
(1981)
Br. Med. J. (Clin. Res. Ed.)
, vol.283
, pp. 577-581
-
-
Egger, J.1
Brett, E.M.2
-
64
-
-
0035169085
-
Prevalence and risk of thrombocytopenia with valproic acid: Experience at a psychiatric teaching hospital
-
E.L. Conley K.C. Coley B.G. Pollock S.V. Dapos R. Maxwell R.A. Branch Prevalence and risk of thrombocytopenia with valproic acid: Experience at a psychiatric teaching hospital Pharmacotherapy 21 2001 1325-1330
-
(2001)
Pharmacotherapy
, vol.21
, pp. 1325-1330
-
-
Conley, E.L.1
Coley, K.C.2
Pollock, B.G.3
Dapos, S.V.4
Maxwell, R.5
Branch, R.A.6
-
65
-
-
0029925182
-
Valproic acid hepatic fatalities. III. US experience since 1986
-
A.E. Bryant III F.E. Dreifuss Valproic acid hepatic fatalities. III. US experience since 1986 Neurology 46 1996 465-469
-
(1996)
Neurology
, vol.46
, pp. 465-469
-
-
Bryant III, A.E.1
Dreifuss, F.E.2
-
66
-
-
0242499953
-
New CNS-active drugs which are second-generation valproic acid: Can they lead to the development of a magic bullet?
-
N. Isoherranen B. Yagen M. Bialer New CNS-active drugs which are second-generation valproic acid: Can they lead to the development of a magic bullet? Curr Opin Neurol 16 2003 203-211
-
(2003)
Curr. Opin. Neurol.
, vol.16
, pp. 203-211
-
-
Isoherranen, N.1
Yagen, B.2
Bialer, M.3
-
67
-
-
0000886469
-
Valproic acid mechanism of action
-
Levy JR, Mattson RH, Meldrum BS (eds) 4th ed. Raven Press, New York
-
Fariello RG, Varasi M, Smith MC. Valproic acid mechanism of action. In: Levy JR, Mattson RH, Meldrum BS (eds) Antiepileptic Drugs, 4th ed. Raven Press, New York, pp 581-588.
-
Antiepileptic Drugs
, pp. 581-588
-
-
Fariello, R.G.1
Varasi, M.2
Smith, M.C.3
-
69
-
-
0032873381
-
Actions of sodium valproate on the central nervous system
-
G. Tunnicliff Actions of sodium valproate on the central nervous system J Physiol Pharmacol 50 1999 347-365
-
(1999)
J. Physiol. Pharmacol.
, vol.50
, pp. 347-365
-
-
Tunnicliff, G.1
-
71
-
-
0022469420
-
Differential effect of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurones and astrocytes
-
O.M. Larsson L. Gram I. Schousboe A. Schousboe Differential effect of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurones and astrocytes Neuropharmacology 25 1986 617-625
-
(1986)
Neuropharmacology
, vol.25
, pp. 617-625
-
-
Larsson, O.M.1
Gram, L.2
Schousboe, I.3
Schousboe, A.4
-
72
-
-
0036810240
-
Lithium and valproic acid: Parallels and contrasts in diverse signaling contexts
-
N. Gurvich P.S. Klein Lithium and valproic acid: Parallels and contrasts in diverse signaling contexts Pharmacol Ther 96 2002 45-66
-
(2002)
Pharmacol. Ther.
, vol.96
, pp. 45-66
-
-
Gurvich, N.1
Klein, P.S.2
-
74
-
-
0033118779
-
Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures
-
O.A. Petroff D.L. Rothman K.L. Behar F. Hyder R.H. Mattson Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures Seizure 8 1999 120-127
-
(1999)
Seizure
, vol.8
, pp. 120-127
-
-
Petroff, O.A.1
Rothman, D.L.2
Behar, K.L.3
Hyder, F.4
Mattson, R.H.5
-
75
-
-
0347722453
-
Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: Role of the glutamatergic system
-
C.A. Zarate Jr J. Du J. Quiroz et al. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: Role of the glutamatergic system Ann NY Acad Sci 1003 2003 273-291
-
(2003)
Ann. NY Acad. Sci.
, vol.1003
, pp. 273-291
-
-
Zarate Jr., C.A.1
Du, J.2
Quiroz, J.3
-
76
-
-
0027495614
-
Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants
-
K.G. Steppuhn L. Turski Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants J Pharmacol Exp Ther 265 1993 1063-1070
-
(1993)
J. Pharmacol. Exp. Ther.
, vol.265
, pp. 1063-1070
-
-
Steppuhn, K.G.1
Turski, L.2
-
77
-
-
0346461606
-
Lithium regulates total and synaptic expression of the AMPA glutamate receptor GluR2 in vitro and in vivo
-
N.A. Gray J. Du C.S. Falke P. Yuan H.K. Manji Lithium regulates total and synaptic expression of the AMPA glutamate receptor GluR2 in vitro and in vivo Ann NY Acad Sci 1003 2003 402-404
-
(2003)
Ann. NY Acad. Sci.
, vol.1003
, pp. 402-404
-
-
Gray, N.A.1
Du, J.2
Falke, C.S.3
Yuan, P.4
Manji, H.K.5
-
78
-
-
0347091908
-
Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression
-
J. Du N.A. Gray C. Falke P. Yuan S. Szabo H.K. Manji Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression Ann NY Acad Sci 1003 2003 378-380
-
(2003)
Ann. NY Acad. Sci.
, vol.1003
, pp. 378-380
-
-
Du, J.1
Gray, N.A.2
Falke, C.3
Yuan, P.4
Szabo, S.5
Manji, H.K.6
-
80
-
-
0029693220
-
The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation
-
C. Van Lint S. Emiliani E. Verdin The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation Gene Expr 5 1996 245-253
-
(1996)
Gene Expr.
, vol.5
, pp. 245-253
-
-
Van Lint, C.1
Emiliani, S.2
Verdin, E.3
-
81
-
-
0037925520
-
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
-
O.H. Kramer P. Zhu H.P. Ostendorff et al. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 Eur Mol Biol Org J 22 2003 3411-3420
-
(2003)
Eur. Mol. Biol. Org. J.
, vol.22
, pp. 3411-3420
-
-
Kramer, O.H.1
Zhu, P.2
Ostendorff, H.P.3
-
82
-
-
0035805569
-
Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis
-
D.L. Vaden D. Ding B. Peterson M.L. Greenberg Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis J Biol Chem 276 2001 15466-15471
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 15466-15471
-
-
Vaden, D.L.1
Ding, D.2
Peterson, B.3
Greenberg, M.L.4
-
83
-
-
0032560117
-
Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3
-
S.E. Rundlett A.A. Carmen N. Suka B.M. Turner M. Grunstein Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3 Nature 392 1998 831-835
-
(1998)
Nature
, vol.392
, pp. 831-835
-
-
Rundlett, S.E.1
Carmen, A.A.2
Suka, N.3
Turner, B.M.4
Grunstein, M.5
-
84
-
-
0034018540
-
Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate
-
M. Murray M.L. Greenberg Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate Mol Microbiol 36 2000 651-661
-
(2000)
Mol. Microbiol.
, vol.36
, pp. 651-661
-
-
Murray, M.1
Greenberg, M.L.2
-
85
-
-
0037161744
-
HDAC6 is a microtubule-associated deacetylase
-
C. Hubbert A. Guardiola R. Shao et al. HDAC6 is a microtubule-associated deacetylase Nature 417 2002 455-458
-
(2002)
Nature
, vol.417
, pp. 455-458
-
-
Hubbert, C.1
Guardiola, A.2
Shao, R.3
-
86
-
-
12244295468
-
In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation
-
A. Matsuyama T. Shimazu Y. Sumida et al. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation Eur Mol Biol Org J 21 2002 6820-6831
-
(2002)
Eur. Mol. Biol. Org. J.
, vol.21
, pp. 6820-6831
-
-
Matsuyama, A.1
Shimazu, T.2
Sumida, Y.3
-
87
-
-
0036479127
-
Molecular cloning and characterization of a novel histone deacetylase HDAC10
-
A.R. Guardiola T.P. Yao Molecular cloning and characterization of a novel histone deacetylase HDAC10 J Biol Chem 277 2002 3350-3356
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 3350-3356
-
-
Guardiola, A.R.1
Yao, T.P.2
-
88
-
-
0347416976
-
The missing linker: An unexpected role for a histone deacetylase
-
R.R. Kopito The missing linker: An unexpected role for a histone deacetylase Mol Cell 12 2003 1349-1351
-
(2003)
Mol. Cell
, vol.12
, pp. 1349-1351
-
-
Kopito, R.R.1
-
89
-
-
0033231056
-
New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: Activation of the peroxisomal proliferator-activated receptor (PPARdelta)
-
A. Lampen S. Siehler U. Ellerbeck M. Gottlicher H. Nau New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: Activation of the peroxisomal proliferator-activated receptor (PPARdelta) Toxicol Appl Pharmacol 160 1999 238-249
-
(1999)
Toxicol. Appl. Pharmacol.
, vol.160
, pp. 238-249
-
-
Lampen, A.1
Siehler, S.2
Ellerbeck, U.3
Gottlicher, M.4
Nau, H.5
-
90
-
-
0037168650
-
An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability
-
L. Tremolizzo G. Carboni W.B. Ruzicka et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability Proc Natl Acad Sci USA 99 2002 17095-17100
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 17095-17100
-
-
Tremolizzo, L.1
Carboni, G.2
Ruzicka, W.B.3
-
91
-
-
0038380334
-
Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus
-
E. Yildirim Z. Zhang T. Uz C.Q. Chen R. Manev H. Manev Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus Neurosci Lett 345 2003 141-143
-
(2003)
Neurosci. Lett.
, vol.345
, pp. 141-143
-
-
Yildirim, E.1
Zhang, Z.2
Uz, T.3
Chen, C.Q.4
Manev, R.5
Manev, H.6
-
92
-
-
3042651448
-
Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: Potential roles of histone deacetylase inhibition and heat shock protein induction
-
M. Ren Y. Leng M. Jeong P.R. Leeds D.M. Chuang Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction J Neurochem 89 2004 1358-1367
-
(2004)
J. Neurochem.
, vol.89
, pp. 1358-1367
-
-
Ren, M.1
Leng, Y.2
Jeong, M.3
Leeds, P.R.4
Chuang, D.M.5
-
93
-
-
85047694248
-
Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop
-
H. Kook J.J. Lepore A.D. Gitler et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop J Clin Invest 112 2003 863-871
-
(2003)
J. Clin. Invest.
, vol.112
, pp. 863-871
-
-
Kook, H.1
Lepore, J.J.2
Gitler, A.D.3
-
95
-
-
0032574977
-
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
-
X. Nan H.H. Ng C.A. Johnson et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex Nature 393 1998 386-389
-
(1998)
Nature
, vol.393
, pp. 386-389
-
-
Nan, X.1
Ng, H.H.2
Johnson, C.A.3
-
96
-
-
0031837109
-
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
-
P.L. Jones G.J. Veenstra P.A. Wade et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription Nat Genet 19 1998 187-191
-
(1998)
Nat. Genet.
, vol.19
, pp. 187-191
-
-
Jones, P.L.1
Veenstra, G.J.2
Wade, P.A.3
-
98
-
-
0042346416
-
Valproate induces replication-independent active DNA demethylation
-
N. Detich V. Bovenzi M. Szyf Valproate induces replication-independent active DNA demethylation J Biol Chem 278 2003 27586-27592
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 27586-27592
-
-
Detich, N.1
Bovenzi, V.2
Szyf, M.3
-
99
-
-
1642309652
-
DNA methylation as an epigenetic regulator of neural 5-lipoxygenase expression: Evidence in human NT2 and NT2-N cells
-
Z. Zhang C.Q. Chen H. Manev DNA methylation as an epigenetic regulator of neural 5-lipoxygenase expression: Evidence in human NT2 and NT2-N cells J Neurochem 88 2004 1424-1430
-
(2004)
J. Neurochem.
, vol.88
, pp. 1424-1430
-
-
Zhang, Z.1
Chen, C.Q.2
Manev, H.3
-
100
-
-
0043240266
-
The role of the extracellular signal-regulated kinase signaling pathway in mood modulation
-
H. Einat P. Yuan T.D. Gould et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation J Neurosci 23 2003 7311-7316
-
(2003)
J. Neurosci.
, vol.23
, pp. 7311-7316
-
-
Einat, H.1
Yuan, P.2
Gould, T.D.3
-
101
-
-
0034981862
-
Bipolar disorder: Leads from the molecular and cellular mechanisms of action of mood stabilizers
-
H.K. Manji G.J. Moore G. Chen Bipolar disorder: Leads from the molecular and cellular mechanisms of action of mood stabilizers Br J Psychiatr Suppl 41 2001 s107-s119
-
(2001)
Br. J. Psychiatr. Suppl.
, vol.41
-
-
Manji, H.K.1
Moore, G.J.2
Chen, G.3
-
102
-
-
0037688084
-
Finding the intracellular signaling pathways affected by mood disorder treatments
-
J.T. Coyle R.S. Duman Finding the intracellular signaling pathways affected by mood disorder treatments Neuron 38 2003 157-160
-
(2003)
Neuron
, vol.38
, pp. 157-160
-
-
Coyle, J.T.1
Duman, R.S.2
-
103
-
-
0038643052
-
The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders
-
N.A. Gray R. Zhou J. Du G.J. Moore H.K. Manji The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders J Clin Psychiatr 64 Suppl 5 2003 3-17
-
(2003)
J. Clin. Psychiatr.
, vol.64
, Issue.SUPPL. 5
, pp. 3-17
-
-
Gray, N.A.1
Zhou, R.2
Du, J.3
Moore, G.J.4
Manji, H.K.5
-
104
-
-
2342511431
-
Mood stabilizers: Protecting the mood... protecting the brain
-
N. Brunello Mood stabilizers: Protecting the mood... protecting the brain J Affect Disord 79 Suppl 1 2004 S15-20
-
(2004)
J. Affect Disord.
, vol.79
, Issue.SUPPL. 1
-
-
Brunello, N.1
-
105
-
-
4243196940
-
Emerging experimental therapeutics for bipolar disorder: Insights from the molecular and cellular actions of current mood stabilizers
-
T.D. Gould J.A. Quiroz J. Singh C.A. Zarate H.K. Manji Emerging experimental therapeutics for bipolar disorder: Insights from the molecular and cellular actions of current mood stabilizers Mol Psychiatr 2004
-
(2004)
Mol. Psychiatr.
-
-
Gould, T.D.1
Quiroz, J.A.2
Singh, J.3
Zarate, C.A.4
Manji, H.K.5
-
106
-
-
0008836304
-
Lithium, phosphatidylinositol signaling, and bipolar disorder
-
Manji HK, Bowden CL, Belmaker RH, editors Washington, DC; American Psychiatric Press
-
Atack JR. Lithium, phosphatidylinositol signaling, and bipolar disorder. In: Manji HK, Bowden CL, Belmaker RH, editors. Bipolar medications mechanisms of action. Washington, DC; American Psychiatric Press, p.1-31.
-
Bipolar Medications Mechanisms of Action
, pp. 1-31
-
-
Atack, J.R.1
-
109
-
-
0037118050
-
A common mechanism of action for three mood-stabilizing drugs
-
R.S. Williams L. Cheng A.W. Mudge A.J. Harwood A common mechanism of action for three mood-stabilizing drugs Nature 417 2002 292-295
-
(2002)
Nature
, vol.417
, pp. 292-295
-
-
Williams, R.S.1
Cheng, L.2
Mudge, A.W.3
Harwood, A.J.4
-
110
-
-
0034598921
-
Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling
-
A.C. Hall F.R. Lucas P.C. Salinas Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling Cell 100 2000 525-535
-
(2000)
Cell
, vol.100
, pp. 525-535
-
-
Hall, A.C.1
Lucas, F.R.2
Salinas, P.C.3
-
111
-
-
0031800971
-
Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium
-
F.R. Lucas R.G. Goold P.R. Gordon-Weeks P.C. Salinas Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium J Cell Sci 111 1998 1351-1361
-
(1998)
J. Cell Sci.
, vol.111
, pp. 1351-1361
-
-
Lucas, F.R.1
Goold, R.G.2
Gordon-Weeks, P.R.3
Salinas, P.C.4
-
112
-
-
0031469645
-
WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons
-
F.R. Lucas P.C. Salinas WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons Dev Biol 192 1997 31-44
-
(1997)
Dev. Biol.
, vol.192
, pp. 31-44
-
-
Lucas, F.R.1
Salinas, P.C.2
-
113
-
-
0033601337
-
The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation
-
C.L. Sayas M.T. Moreno-Flores J. Avila F. Wandosell The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation J Biol Chem 274 1999 37046-37052
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 37046-37052
-
-
Sayas, C.L.1
Moreno-Flores, M.T.2
Avila, J.3
Wandosell, F.4
-
114
-
-
0032748099
-
Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones
-
R.G. Goold R. Owen P.R. Gordon-Weeks Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones J Cell Sci 112 1999 3373-3384
-
(1999)
J. Cell Sci.
, vol.112
, pp. 3373-3384
-
-
Goold, R.G.1
Owen, R.2
Gordon-Weeks, P.R.3
-
115
-
-
0037092042
-
An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling
-
B.J. Eickholt F.S. Walsh P. Doherty An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling J Cell Biol 157 2002 211-217
-
(2002)
J. Cell Biol.
, vol.157
, pp. 211-217
-
-
Eickholt, B.J.1
Walsh, F.S.2
Doherty, P.3
-
116
-
-
0028236025
-
Towards a crystal-clear view of lithium's site of action
-
J. Baraban Towards a crystal-clear view of lithium's site of action Proc Natl Acad Sci USA 91 1994 5738-5739
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 5738-5739
-
-
Baraban, J.1
-
117
-
-
0034644861
-
Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain
-
T. O'Donnell S. Rotzinger T.T. Nakashima C.C. Hanstock M. Ulrich P.H. Silverstone Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain Brain Res 880 2000 84-91
-
(2000)
Brain Res.
, vol.880
, pp. 84-91
-
-
O'Donnell, T.1
Rotzinger, S.2
Nakashima, T.T.3
Hanstock, C.C.4
Ulrich, M.5
Silverstone, P.H.6
-
118
-
-
0038719771
-
+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea
-
+ /myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea J Biol Chem 278 2003 18297-18302
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 18297-18302
-
-
Berry, G.T.1
Wu, S.2
Buccafusca, R.3
-
119
-
-
1942489264
-
Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain
-
G.T. Berry R. Buccafusca J.J. Greer E. Eccleston Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain Mol Genet Metab 82 2004 87-92
-
(2004)
Mol. Genet. Metab.
, vol.82
, pp. 87-92
-
-
Berry, G.T.1
Buccafusca, R.2
Greer, J.J.3
Eccleston, E.4
-
120
-
-
0036788036
-
The Wnt signaling pathway in bipolar disorder
-
T.D. Gould H.K. Manji The Wnt signaling pathway in bipolar disorder Neuroscientist 8 2002 497-511
-
(2002)
Neuroscientist
, vol.8
, pp. 497-511
-
-
Gould, T.D.1
Manji, H.K.2
-
121
-
-
0033817339
-
Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator
-
A.N. Billin H. Thirlwell D.E. Ayer Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator Mol Cell Biol 20 2000 6882-6890
-
(2000)
Mol. Cell Biol.
, vol.20
, pp. 6882-6890
-
-
Billin, A.N.1
Thirlwell, H.2
Ayer, D.E.3
-
122
-
-
0035312290
-
All Tcf HMG box transcription factors interact with Groucho-related co-repressors
-
H. Brantjes J. Roose M. van De Wetering H. Clevers All Tcf HMG box transcription factors interact with Groucho-related co-repressors Nucleic Acids Res 29 2001 1410-1419
-
(2001)
Nucleic Acids Res.
, vol.29
, pp. 1410-1419
-
-
Brantjes, H.1
Roose, J.2
van De Wetering, M.3
Clevers, H.4
-
123
-
-
0033014180
-
The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3
-
G. Chen L.D. Huang Y.M. Jiang H.K. Manji The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3 J Neurochem 72 1999 1327-1330
-
(1999)
J. Neurochem.
, vol.72
, pp. 1327-1330
-
-
Chen, G.1
Huang, L.D.2
Jiang, Y.M.3
Manji, H.K.4
-
124
-
-
0036311668
-
Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons
-
A.C. Hall A. Brennan R.G. Goold et al. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons Mol Cell Neurosci 20 2002 257-270
-
(2002)
Mol. Cell Neurosci.
, vol.20
, pp. 257-270
-
-
Hall, A.C.1
Brennan, A.2
Goold, R.G.3
-
125
-
-
0036909443
-
Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium
-
P. De Sarno X. Li R.S. Jope Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium Neuropharmacology 43 2002 1158-1164
-
(2002)
Neuropharmacology
, vol.43
, pp. 1158-1164
-
-
De Sarno, P.1
Li, X.2
Jope, R.S.3
-
126
-
-
2342425038
-
Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport
-
Y. Tatebayashi N. Haque Y.C. Tung K. Iqbal I. Grundke-Iqbal Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport J Cell Sci 117 2004 1653-1663
-
(2004)
J. Cell Sci.
, vol.117
, pp. 1653-1663
-
-
Tatebayashi, Y.1
Haque, N.2
Tung, Y.C.3
Iqbal, K.4
Grundke-Iqbal, I.5
-
127
-
-
0035943699
-
The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth
-
P.X. Yuan L.D. Huang Y.M. Jiang J.S. Gutkind H.K. Manji G. Chen The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth J Biol Chem 276 2001 31674-31683
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 31674-31683
-
-
Yuan, P.X.1
Huang, L.D.2
Jiang, Y.M.3
Gutkind, J.S.4
Manji, H.K.5
Chen, G.6
-
128
-
-
0034795827
-
Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain
-
T. Fukumoto S. Morinobu Y. Okamoto A. Kagaya S. Yamawaki Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain Psychopharmacology 158 2001 100-106
-
(2001)
Psychopharmacology
, vol.158
, pp. 100-106
-
-
Fukumoto, T.1
Morinobu, S.2
Okamoto, Y.3
Kagaya, A.4
Yamawaki, S.5
-
129
-
-
0842328581
-
Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs
-
T.W. Corson K.K. Woo P.P. Li J.J. Warsh Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs Eur Neuropsychopharmacol 14 2004 143-150
-
(2004)
Eur. Neuropsychopharmacol.
, vol.14
, pp. 143-150
-
-
Corson, T.W.1
Woo, K.K.2
Li, P.P.3
Warsh, J.J.4
-
130
-
-
0032956630
-
The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS
-
G. Chen W.Z. Zeng P.X. Yuan et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS J Neurochem 72 1999 879-882
-
(1999)
J. Neurochem.
, vol.72
, pp. 879-882
-
-
Chen, G.1
Zeng, W.Z.2
Yuan, P.X.3
-
131
-
-
1042267223
-
Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells
-
N. Takai J.C. Desmond T. Kumagai et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells Clin Cancer Res 10 2004 1141-1149
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 1141-1149
-
-
Takai, N.1
Desmond, J.C.2
Kumagai, T.3
-
132
-
-
0032409781
-
Bcl-2 family proteins
-
J.C. Reed Bcl-2 family proteins Oncogene 17 1998 3225-3236
-
(1998)
Oncogene
, vol.17
, pp. 3225-3236
-
-
Reed, J.C.1
-
133
-
-
0036116367
-
Neuroprotective effects of lithium in cultured cells and animal models of diseases
-
D.M. Chuang R.W. Chen E. Chalecka-Franaszek et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases Bipolar Disord 4 2002 129-136
-
(2002)
Bipolar Disord.
, vol.4
, pp. 129-136
-
-
Chuang, D.M.1
Chen, R.W.2
Chalecka-Franaszek, E.3
-
134
-
-
3342955475
-
Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium
-
W.T. O'Brien A.D. Harper F. Jové et al. Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium J Neurosci 24 2004 6791-6798
-
(2004)
J. Neurosci.
, vol.24
, pp. 6791-6798
-
-
O'Brien, W.T.1
Harper, A.D.2
Jové, F.3
-
135
-
-
0029776032
-
A molecular mechanism for the effect of lithium on development
-
P.S. Klein D.A. Melton A molecular mechanism for the effect of lithium on development Proc Natl Acad Sci USA 93 1996 8455-8459
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 8455-8459
-
-
Klein, P.S.1
Melton, D.A.2
-
136
-
-
0024791065
-
Potential antidepressant properties of subchronic GABA transaminase inhibitors in the forced swimming test in mice
-
J. Semba Y. Kuroda R. Takahashi Potential antidepressant properties of subchronic GABA transaminase inhibitors in the forced swimming test in mice Neuropsychobiology 21 1989 152-156
-
(1989)
Neuropsychobiology
, vol.21
, pp. 152-156
-
-
Semba, J.1
Kuroda, Y.2
Takahashi, R.3
-
137
-
-
0024549796
-
Sodium valproate and chlordiazepoxide in the elevated plus-maze test of anxiety in the rat
-
S.E. File K. Aranko Sodium valproate and chlordiazepoxide in the elevated plus-maze test of anxiety in the rat Neuropsychobiology 20 1988 82-86
-
(1988)
Neuropsychobiology
, vol.20
, pp. 82-86
-
-
File, S.E.1
Aranko, K.2
-
138
-
-
0026099433
-
Effect of antiepileptic drugs valproic acid, carbamazepine and ethosuccimide on exploratory behaviour in mice
-
S. Rao K.R. Rajesh T. Joseph Effect of antiepileptic drugs valproic acid, carbamazepine and ethosuccimide on exploratory behaviour in mice Indian J Exp Biol 29 1991 127-130
-
(1991)
Indian J. Exp. Biol.
, vol.29
, pp. 127-130
-
-
Rao, S.1
Rajesh, K.R.2
Joseph, T.3
-
139
-
-
0005097730
-
Animal models for mania
-
Murphy DL. Animal models for mania.
-
-
-
Murphy, D.L.1
-
140
-
-
1842787936
-
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
-
J.M. Beaulieu T.D. Sotnikova W.D. Yao et al. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc Natl Acad Sci USA 101 2004 5099-5104
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 5099-5104
-
-
Beaulieu, J.M.1
Sotnikova, T.D.2
Yao, W.D.3
-
141
-
-
0027319477
-
Magnesium valproate attenuates hyperactivity induced by dexamphetamine-chlordiazepoxide mixture in rodents
-
B.J. Cao N.A. Peng Magnesium valproate attenuates hyperactivity induced by dexamphetamine-chlordiazepoxide mixture in rodents Eur J Pharmacol 237 1993 177-181
-
(1993)
Eur. J. Pharmacol.
, vol.237
, pp. 177-181
-
-
Cao, B.J.1
Peng, N.A.2
-
142
-
-
0037441746
-
Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system
-
R.J. Ralph-Williams M.P. Paulus X. Zhuang R. Hen M.A. Geyer Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system Biol Psychiatr 53 2003 352-359
-
(2003)
Biol. Psychiatr.
, vol.53
, pp. 352-359
-
-
Ralph-Williams, R.J.1
Paulus, M.P.2
Zhuang, X.3
Hen, R.4
Geyer, M.A.5
|